Thibault Lavalleye
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Thibault Lavalleye has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Antoine Laffalize
Laboratory of Clinical Chemistry , 70492 Cliniques Universitaires Saint-Luc, UCLouvain , Brussels , Belgium
1 shared publicationCatherine Lambert
Hemostasis and Thrombosis Unit, Division of Hematology Cliniques Universitaires Saint‐Luc, UCLouvain Brussels Belgium
1 shared publication- Catherine de Magnée
Department of Pediatric Surgery and Liver Transplantation, Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
1 shared publication - Corentin Streel
Hematology Department of Laboratory Medicine, Cliniques Universitaires Saint-Luc, UCLouvain, Brussels, Belgium; Cliniques Universitaires Saint-Luc, 10 Avenue Mounier, Brussels 1200, Belgium
1 shared publication Damien Gruson
Laboratory of Clinical Chemistry , 70492 Cliniques Universitaires Saint-Luc, UCLouvain , Brussels , Belgium
1 shared publicationDominique Maiter
Endocrinology Department , 70492 Cliniques Universitaires Saint-Luc, UCLouvain , Brussels , Belgium
1 shared publication
Latest Publications
- 21 October 2025
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (6) , 104264
Passenger lymphocyte syndrome: A rare cause of post-transplant hemolysis following minor ABO-incompatible living donor liver transplantation
- 21 October 2025
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 64 (6) , 104264
Passenger lymphocyte syndrome: A rare cause of post-transplant hemolysis following minor ABO-incompatible living donor liver transplantation
- 5 July 2024
- Published by Wiley in Transfusion
- Vol. 64 (9) , 1743-1751
Method comparison between hematopoietic progenitor cell and CD34+ cell counts in hematopoietic stem cell collection
Background: The reference method for hematopoietic stem cell enumeration is flow cytometric CD34+ cell analysis. We evaluated using the hematopoietic progenitor cell (HPC) count on the Sysmex hematology analyzer to safely replace some flow cytometric measurements performed in peripheral blood samples to guide apheresis timing.Study Design and Methods: We compared HPC and CD34+ cell counts in 133 preharvest peripheral blood samples and 124 apheresis products.Results: Pre‐apheresis HPC counts ≥24 × 106/L in healthy donors and ≥36 × 106/L in lymphoma patients predicted adequate mobilization with 100% specificity and positive predictive value, saving 79% and 63% of flow cytometry analyses, respectively. Due to a positive bias (mean bias 50.26; 95% CI 36.24–64.29), a higher threshold was needed in multiple myeloma patients (HPC 132 × 106/L), saving only 24% of flow cytometry analyses.Conclusion: When the HPC count is above the corresponding threshold, apheresis could be safely initiated without waiting for the flow cytometry result, thereby reducing time‐to‐decision. Lower HPC values, however, require confirmation by flow cytometry.
- 5 July 2024
- Published by Wiley in Transfusion
- Vol. 64 (9) , 1743-1751
Method comparison between hematopoietic progenitor cell and CD34+ cell counts in hematopoietic stem cell collection
Background: The reference method for hematopoietic stem cell enumeration is flow cytometric CD34+ cell analysis. We evaluated using the hematopoietic progenitor cell (HPC) count on the Sysmex hematology analyzer to safely replace some flow cytometric measurements performed in peripheral blood samples to guide apheresis timing.Study Design and Methods: We compared HPC and CD34+ cell counts in 133 preharvest peripheral blood samples and 124 apheresis products.Results: Pre‐apheresis HPC counts ≥24 × 106/L in healthy donors and ≥36 × 106/L in lymphoma patients predicted adequate mobilization with 100% specificity and positive predictive value, saving 79% and 63% of flow cytometry analyses, respectively. Due to a positive bias (mean bias 50.26; 95% CI 36.24–64.29), a higher threshold was needed in multiple myeloma patients (HPC 132 × 106/L), saving only 24% of flow cytometry analyses.Conclusion: When the HPC count is above the corresponding threshold, apheresis could be safely initiated without waiting for the flow cytometry result, thereby reducing time‐to‐decision. Lower HPC values, however, require confirmation by flow cytometry.
- 12 June 2024
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 62 (12) , e263-e264
Spurious parathyroid hormone (PTH) elevation caused by macro-PTH
Article Spurious parathyroid hormone (PTH) elevation caused by macro-PTH was published on June 12, 2024 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 0, issue 0).
- 12 June 2024
- Published by Walter de Gruyter GmbH in Clinical Chemistry and Laboratory Medicine (CCLM)
- Vol. 62 (12) , e263-e264
Spurious parathyroid hormone (PTH) elevation caused by macro-PTH
Article Spurious parathyroid hormone (PTH) elevation caused by macro-PTH was published on June 12, 2024 in the journal Clinical Chemistry and Laboratory Medicine (CCLM) (volume 0, issue 0).